Throne Science: Passive Health Monitoring in the Bathroom

Going further than an ordinary wearable, Throne Science is  a toilet-mounted sensor that uses computer vision, acoustic sensing, and AI to turn routine bathroom visits into longitudinal health data. The big picture is whether passive passive health monitoring can eventually support colon cancer research and prevention.

Image

Throne Science Turns Your Regular Toilet Break Into Passive Health Monitoring

Throne One is a specialised sensor that clips onto a standard toilet and activates for a recognised user.

The technology startup was co-founded by former WHOOP Chief Technology Officer, John Capodilupo, who is himself a sufferer of the gut condition ulcerative colitis.

Throne’s optical and acoustic sensors capture information about stool and urine without manual logging, while AI models process the session and present trends through the sensor’s app.

The technology focuses on gut health, hydration, urinary function, and bathroom habits, with stool form classified using the Bristol Stool Scale.

That’s remarkably different from a conventional wearable, to say the least.

Additionally, users do not need to remember symptoms or maintain a diary.

The technology company’s longer-term ambition is to investigate whether continuously captured stool and urinary signals could support earlier detection of colorectal and lower gastrointestinal cancers.

However, the Throne Science current product remains, so far, a general wellness device, rather than a diagnostic tool.

Bathroom Habits: Passive Data Matters

Throne’s value is the company’s unique passive data collection that represents a longitudinal record of a user’s bowel habits.

A single stool or urine sample may provide limited context, while Throne’s repeated observations can establish an individual’s normal pattern and make changes easier to identify.

That is particularly important where manual reporting can limit available data, such as with bathroom habits.

Stool contains clinically relevant biological signals. DNA, RNA, proteins, microbial markers, and other stool-associated biomarkers are all associated with the risk of developing colorectal cancer.

Strong diagnostic potential has been shown with several stool biomarker approaches, with performance varying in clinical research and significant challenges persisting, especially around sensitivity and any study patient participation. 

Throne attempts to capture any biomarker and other observable characteristics automatically and repeatedly.

View interview How Should Pharma Companies Audit AI Vendors?

How Should Pharma Companies Audit AI Vendors?

“This is one of the riskiest industries there is because you're dealing with human lives, you're dealing with experimental protocols, and you're dealing with regulatory bodies where you might not get another shot at that clinical trial."

Image

With Throne, AI Layer Is Only Part of the Technology Stack

The Throne Science technology is not simply an AI application as it combines sensing, computer vision, acoustic analysis, cloud processing, longitudinal data, and personalised interpretation altogether.

Throne says its AI has been trained using clinician-labelled data and its privacy architecture includes user activation, downward-facing sensing, encryption, and controls over data sharing.

Image

That’s proving to be important for regulation. A wellness device data signal is not the same as a validated clinical endpoint or diagnostic output.

The U.S. Food and Drug Administration (FDA) has a specific digital health framework setting expectations around clinical evaluation and oversight for software used as a medical device. 

Throne recognises this, and while its potential cancer-detection role remains a future objective, it requires rigorous clinical validation and regulatory work.

Throne Science Series A Funding

Throne Science announced a U.S. $10 million Series A funding round, led by Will Ventures, with participation from a group of additional investors.

The company says the funding will support engineering and science talent, next-generation sensing hardware, research, and clinical validation as it develops its platform.

Watch Passive Health Monitoring and Wearable Digital Data

Throne illustrates a broader movement towards passive, real-world health data.

If Throne Science demonstrates clinical validity, similar approaches could eventually contribute to longitudinal research, digital biomarkers, patient stratification, or symptom monitoring.

Three developments will determine whether Throne technology moves beyond consumer wellness:

• Clinical validation: Can sensor-derived signals correlate reliably with meaningful clinical outcomes?
• Regulatory evidence: Can performance be demonstrated for a defined medical purpose?
• Data integration: Can longitudinal signals connect securely with clinical research and healthcare workflows?

Continuous data creates value only when it can be interpreted, validated, and incorporated into an evidence framework.

Throne Blazes Technology Path for Passive Health Monitoring and Gut Health 

Throne’s technology offers a technological future where health signals are captured during ordinary life rather than only during appointments or formal tests.

These streams could eventually complement biomarkers, clinical endpoints, and patient-generated data.

The technology remains at an early-stage, and its cancer-detection role has not been clinically established.

Throne Science’s potential clinical research use and health prevention opportunity, rather than its 2026 U.S. $10-million Series A funding, is the real story worth watching.

At Pharmatica, we provide top expert-led Insights into the technologies shaping pharmaceutical R&D, digital health, and clinical development. We connect the evidence, regulation, and commercial impact of innovative health technology so that decision-makers can act with confidence.

Pharmatica: Insight. Connection. Impact.

Image